Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...

Inhibitors of Virion Maturation and Assembly

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Community HIV-1 drug resistance is associated with transmitted drug resistance.

HIV medicine·2014

Same author

A case cluster demonstrating the relationship between HLA concordance and virologic and disease outcomes in human immunodeficiency virus infection.

Virology·2014

Same author

Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy.

Nature·2012

Same author

Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain.

Neurology·2009

Same author

In vitro evaluation of experimental agents for anti-HIV activity.

Current protocols in immunology·2008

Same author

Estimating selection pressures on HIV-1 using phylogenetic likelihood models.

Statistics in medicine·2008

Same journal

Daily briefing: 'Cyborg' cockroaches breathe underwater with printed suit.

Nature·2026

Same journal

China boosts prestigious grants for young scientists - will it ease competition?

Nature·2026

Same journal

Incoming US science academy chief vows to 'double down' on research.

Nature·2026

Same journal

Author Correction: Synthesis of enantioenriched atropisomers by biocatalytic deracemization.

Nature·2026

Same journal

Electrodeposited self-assembled molecules for perovskite photovoltaics.

Nature·2026

Same journal

Neutrino's nursery found: the 'Shadow Blaster'.

Nature·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 28, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 10, 2014

HIV chemotherapy.

¹Veterans Affairs San Diego Healthcare System and University of California San Diego, Departments of Pathology and Medicine 0679, La Jolla, California 92093-0679, USA. drichman@ucsd.edu

|April 20, 2001

Summary

This summary is machine-generated.

Chemotherapy significantly reduced illness and death from human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS). However, challenges like drug resistance and toxicity necessitate new HIV therapies.

More Related Videos

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

Determining 3'-Termini and Sequences of Nascent Single-Stranded Viral DNA Molecules during HIV-1 Reverse Transcription in Infected Cells

Determining 3'-Termini and Sequences of Nascent Single-Stranded Viral DNA Molecules during HIV-1 Reverse Transcription in Infected Cells

Published on: January 30, 2019

Related Experiment Videos

Last Updated: Jun 28, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 10, 2014

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

Determining 3'-Termini and Sequences of Nascent Single-Stranded Viral DNA Molecules during HIV-1 Reverse Transcription in Infected Cells

Determining 3'-Termini and Sequences of Nascent Single-Stranded Viral DNA Molecules during HIV-1 Reverse Transcription in Infected Cells

Published on: January 30, 2019

Area of Science:

Infectious Diseases
Virology
Pharmacology

Background:

Chemotherapy has dramatically improved outcomes for individuals with human immunodeficiency virus (HIV) infection, leading to reduced AIDS-related morbidity and mortality.
Current HIV therapies have yielded significant insights into viral pathogenesis and host-pathogen dynamics.
Despite advancements, challenges persist, including incomplete viral suppression, the development of drug-resistant HIV strains, and treatment-related toxicities.

Purpose of the Study:

To review the impact of chemotherapy on HIV/AIDS treatment.
To highlight the ongoing challenges in managing HIV infection.
To emphasize the need for novel therapeutic strategies and drugs to overcome current limitations.

Main Methods:

Review of existing literature on HIV chemotherapy.
Analysis of clinical outcomes and treatment efficacy.
Discussion of viral resistance mechanisms and therapeutic toxicity.

Main Results:

Significant reductions in AIDS incidence, mortality, and healthcare utilization have been observed.
HIV therapy has advanced the understanding of viral and cellular dynamics.
Treatment failures due to drug resistance and adverse effects remain significant clinical issues.

Conclusions:

Current chemotherapy regimens have transformed HIV/AIDS management but are not universally effective.
The emergence of drug resistance and treatment toxicity underscore the need for continuous innovation in HIV therapeutics.
Further research into new drugs and treatment strategies is crucial for achieving durable control of HIV replication.